These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4852249)

  • 41. Hepatic organic anion transport following portacaval shunt in patients with cirrhosis.
    Zsigmond GL; Bodnár A; Karácsonyi S
    Acta Chir Hung; 1984; 25(2):97-106. PubMed ID: 6464621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Study of glucose regulation and blood insulin before and after porto-caval anastomosis].
    Azerad E; Lubetzki J; Duprey J; Friedler D
    Diabete; 1967; 15(1):50-6. PubMed ID: 6044410
    [No Abstract]   [Full Text] [Related]  

  • 43. [Diabetic metabolic aberration after porto-systmeic shunt].
    Christensen MF
    Ugeskr Laeger; 1967 Feb; 129(6):195-8. PubMed ID: 5599211
    [No Abstract]   [Full Text] [Related]  

  • 44. Period-amplitude analysis of the electrodencephalogram correlated with liver function in patients with cirrhosis of the liver.
    Kardel T; Stigsby B
    Electroencephalogr Clin Neurophysiol; 1975 Jun; 38(6):605-9. PubMed ID: 50186
    [No Abstract]   [Full Text] [Related]  

  • 45. [The influence of side-to-side portacaval shunt plus enhancement of perfusion of hepatic artery on cirrhotic liver: an experimental study].
    Weng Y; Wang Y; Xue J; Zhang Z; Zhou Y; Chen D; Li C
    Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):487-90. PubMed ID: 11825448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Functional activity of the cirrhotic liver before and after latero-lateral portacaval anastomosis].
    Bucciarelli G; Bechi P; Masi C; Giannini G
    Minerva Med; 1980 Mar; 71(9):693-7. PubMed ID: 7360407
    [No Abstract]   [Full Text] [Related]  

  • 47. Gastrointestinal disorders in chronic alcoholics.
    Dinoso VP; Chey WY; Padow D; Rosen A; Ottenberg D; Lorber SH
    Am J Gastroenterol; 1971 Sep; 56(3):209-15. PubMed ID: 5121543
    [No Abstract]   [Full Text] [Related]  

  • 48. Peripheral neuropathy associated with disulfiram administration.
    Olney RK; Miller RG
    Muscle Nerve; 1980; 3(2):172-5. PubMed ID: 6245358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electrophysiological study of patients with herniated intervertebral discs.
    Drechsler B; Lastovka M; Kalvodova E
    Electromyography; 1966; 6(3):187-204. PubMed ID: 6004653
    [No Abstract]   [Full Text] [Related]  

  • 50. Liver function and encephalopathy after partial vs direct side-to-side portacaval shunt: a prospective randomized clinical trial.
    Capussotti L; Vergara V; Polastri R; Bouzari H; Galatola G
    Surgery; 2000 Jun; 127(6):614-21. PubMed ID: 10840355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Alpha-mercaptopropionylglycine (Thiola) in the treatment of chronic liver diseases with special reference to the effects of the drug on the index of prognosis in alcoholic cirrhosis].
    Mantero O; Conti F; Bertoli L
    Minerva Med; 1974 Feb; 65(9):460-7. PubMed ID: 4820725
    [No Abstract]   [Full Text] [Related]  

  • 52. [Alcoholic neuropathy and thiamine deficiency neuropathy].
    Takahashi K
    No To Shinkei; 1984 Aug; 36(8):729-35. PubMed ID: 6093835
    [No Abstract]   [Full Text] [Related]  

  • 53. Involvement of peripheral sensory fibers in amyotrophic lateral sclerosis: electrophysiological study of 64 cases.
    Mondelli M; Rossi A; Passero S; Guazzi GC
    Muscle Nerve; 1993 Feb; 16(2):166-72. PubMed ID: 8429840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis.
    Gómez-Dominguez E; Mendoza J; García-Buey L; Trapero M; Gisbert JP; Jones EA; Moreno-Otero R
    Aliment Pharmacol Ther; 2008 Mar; 27(5):441-7. PubMed ID: 18081731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparative evaluation of tolerance tests with sulfobromophthalein and with galactose in chronic liver diseases. (Value and limitations of the discriminating analyses used in the 2 tests for diagnosis of hepatic cirrhosis)].
    Coltorti M; Di Simone A; Budillon G; Carrella M; Oriani G
    Policlinico Med; 1968; 75(4):189-215. PubMed ID: 5708459
    [No Abstract]   [Full Text] [Related]  

  • 56. [The role of the serum BG(P-B) value from glucagon loading test in assessing liver function of cirrhosis patients].
    Wu BF; Lin LL; Hu PJ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):186. PubMed ID: 12681076
    [No Abstract]   [Full Text] [Related]  

  • 57. [Subclinical neuromyopathy in nonalcoholic hepatic cirrhosis].
    Rubies-Prat J; Caralps A; Morell F; Crespo F; Marsal J; Espaja R; Moragas A; Bacardí R
    Rev Clin Esp; 1973 Apr; 129(1):53-6. PubMed ID: 4707037
    [No Abstract]   [Full Text] [Related]  

  • 58. [Proximal and distal peripheral nerve conduction in chronic renal insufficiency].
    Fernández Liguori NA; García Erro MI; Pacagnini GE; Campos C; Sica RE
    Medicina (B Aires); 1987; 47(5):477-83. PubMed ID: 3504987
    [No Abstract]   [Full Text] [Related]  

  • 59. Peripheral neuropathy in liver cirrhosis. A clinical and electrophysiological study.
    Perretti A; Gentile S; Balbi P; Persico M; Caruso G
    Ital J Gastroenterol; 1995 Sep; 27(7):349-54. PubMed ID: 8563004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Electroneurographic and electromyographic findings in 50 patients with chronic alcohol abuse].
    Hankowitz M
    Nervenarzt; 1976 Apr; 47(4):272-4. PubMed ID: 1272489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.